In the wake of COVID-19, GOLD investigates the potential impact of unpredictable events on the industry’s complex distribution network to understand its resilience and vulnerability.

The mRNA COVID-19 vaccine took only a year to develop – beating the previous fastest traditional vaccine development, held by the 1967 mumps vaccine, of four years. How does it differ from traditional vaccine technology?

This infographic explores pharmaceutical trade patterns globally, ranking the top importing and exporting countries, spotlighting the manufacturing hotspots to watch, and investigating the impact of COVID-19 on rates of trade internationally.

This infographic tracks the evolution of the industry’s reputation by breaking down the perspectives of individual countries and generations, while also examining the impact of the COVID-19 pandemic on public outlook.

This infographic reviews drug launches from recent years, comparing the expectation vs reality of launch, the increase in first-time launchers, and the impact of COVID-19 on the landscape.

We consider the multi-functional uses and potential of biotechnology, highlight some of the biggest players in biotech, and forecast how the market could ascend in the coming years.

This infographic focusses on the three front runners in the COVID-19 vaccine race, uncovering how the race unfolded, comparing the all-important efficacies and characteristics.

In this infographic, we showcase the top performing orphan drug predictions for 2024 and identify the companies leading the way in this space. We also consider the six key steps for orphan drug launch success.